Okyo Pharma Limited ADR (OKYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 03-2025 | 09-2024 | 03-2024 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,587 | -7,970 | -4,098 | -16,803 | -13,284 |
| Depreciation Amortization | 1 | 3 | 1 | 4 | 4 |
| Accounts payable and accrued liabilities | -639 | N/A | N/A | N/A | N/A |
| Other Working Capital | -1,445 | 1,627 | 2,427 | 2,669 | 3,946 |
| Other Operating Activity | 3,141 | 4,529 | 1,429 | 4,639 | 1,639 |
| Operating Cash Flow | $-1,528 | $-1,811 | $-241 | $-9,491 | $-7,695 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1 | N/A | 0 | -6 |
| Investing Cash Flow | $N/A | $-1 | $N/A | $0 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,317 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 2,656 | 552 | 6,209 | 9,323 |
| Financing Cash Flow | $4,317 | $2,656 | $552 | $6,209 | $9,323 |
| Exchange Rate Effect | -129 | -110 | -150 | 64 | -278 |
| Beginning Cash Position | 1,561 | 827 | 827 | 4,045 | 2,701 |
| End Cash Position | 4,220 | 1,561 | 987 | 827 | 4,045 |
| Net Cash Flow | $2,660 | $734 | $160 | $-3,219 | $1,345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,528 | -1,811 | -241 | -9,491 | -7,695 |
| Free Cash Flow | -1,528 | -1,811 | -241 | -9,491 | -7,695 |